Cresset BioMolecular Discovery Limited Sustainability Profile
Cresset BioMolecular Discovery Limited, a leading name in the field of computational chemistry and molecular modelling, is headquartered in Great Britain. Founded in 2003, the company has established itself as a key player in the pharmaceutical and biotechnology industries, providing innovative solutions for drug discovery and development. Cresset's core offerings include advanced software tools for molecular design, virtual screening, and predictive modelling, which are distinguished by their unique ability to enhance the efficiency of the drug discovery process. With a strong focus on user-friendly interfaces and robust algorithms, Cresset's products empower researchers to make informed decisions quickly. Recognised for its contributions to the field, Cresset has achieved significant milestones, including collaborations with major pharmaceutical companies and a growing presence in global markets. The company continues to drive innovation, solidifying its position as a trusted partner in the quest for new therapeutics.
DitchCarbon Score
How does Cresset BioMolecular Discovery Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cresset BioMolecular Discovery Limited's score of 23 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cresset BioMolecular Discovery Limited's reported carbon emissions
Cresset BioMolecular Discovery Limited, headquartered in Great Britain, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, Cresset BioMolecular Discovery Limited appears to lack formal commitments to carbon reduction initiatives or industry-standard climate targets, such as those set by the Science Based Targets initiative (SBTi). Without emissions data or reduction strategies, it is unclear how the company is addressing its environmental impact or contributing to broader climate goals within the biotechnology sector. In the absence of specific emissions figures or commitments, Cresset's climate strategy remains undefined, highlighting a potential area for future development in sustainability practices.
How Carbon Intensive is Cresset BioMolecular Discovery Limited's Industry?
How Carbon Intensive is Cresset BioMolecular Discovery Limited's Location?
Cresset BioMolecular Discovery Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Cresset BioMolecular Discovery Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
